MD MSc (Stroke Med.) MRCPI Dr Killian O’Rourke, Consultant Neurologist is a 1994 RCSI graduate. He has a particular interest in the use of disease modifying therapy (DMT) as applied to Multiple Sclerosis and Stroke, which are the leading neurological causes of chronic disability affecting younger and older adults respectively. He has published in international journals on the use of DMT in the form of beta-interferon for Multiple Sclerosis, and in the form of thrombolysis “clotbuster” treatment and dedicated stroke units for Stroke. In 2007 he was awarded an MD degree by UCD for his work on the development of treatment failure criteria for DMT in Multiple Sclerosis, and in 2009 he was awarded a Masters degree in Stroke Medicine by the University of Krems, Austria. He has a strong interest in evidence-based medicine and medical statistics, and has been at the forefront of the application of Bayesian statistical methodology to the fields of DMT for Multiple Sclerosis and Stroke. He is a member of the Cochrane Collaboration Stroke Group for whom he heads an ongoing evaluation of interventional radiological approaches to acute Stroke management. In 2007 he was appointed a Health Research Board of Ireland Cochrane Research Fellow.